Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/33183| Title: | Editorial: Overcoming drug relapse and therapy resistance in NSCLC. | Austin Authors: | Parakh, Sagun ;Leong, Tracy L ;Best, Sarah A;Poh, Ashleigh R | Affiliation: | Medical Oncology Respiratory and Sleep Medicine Personalised Oncology Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.;Department of Medical Biology, University of Melbourne, Melbourne, Australia. School of Cancer Medicine, La Trobe University, Melbourne, VIC, Australia. Olivia Newton-John Cancer Research Institute Faculty of Medicine, University of Melbourne, Parkville, VIC, Australia. Department of Medical Biology, University of Melbourne, Melbourne, Australia. |
Issue Date: | 2023 | Date: | 2023 | Publication information: | Frontiers in Oncology 2023; 13 | URI: | https://ahro.austin.org.au/austinjspui/handle/1/33183 | DOI: | 10.3389/fonc.2023.1230475 | ORCID: | Journal: | Frontiers in Oncology | Start page: | 1230475 | PubMed URL: | 37350939 | Type: | Journal Article | Subjects: | EGFR mutation biomarkers drug resistance immunophenotyping metabolism non-small cell lung cancer tumor microenvironment tumor mutational burden (TMB) |
| Appears in Collections: | Journal articles |
Show full item record
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.